SPHK1 and melanoma: As an example, Colacios et al. found that dysregulated sphingolipid metabolism, via sphingosine kinase 1 (SK1) and sphingomyelin synthase 1 (SMS1), in melanoma cells was associated with increased immunosuppressive markers and a more aggressive phenotype [115,116].